New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
08:48 EDTQGENQIAGEN price target raised to $26 from $20 at RW Baird
Baird raised its price target on QIAGEN following better than expected Q4 results. The firm cited higher guidance, tangible drivers of organic growth, and cash available for accretive use. Shares are Outperform rated.
News For QGEN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
16:12 EDTQGENQIAGEN sees Q3 adjusted EPS 29c-30c, consensus 29c
Subscribe for More Information
16:11 EDTQGENQIAGEN sees FY15 adjusted EPS $1.16-1.18, consensus $1.10
Sees FY15 adjusted net sales to rise approximately 4% CER in 2015, as growth of about 7-8% CER in the core portfolio exceeds the adverse impact of approximately 3-4 percentage points from lower U.S. HPV sales. FY15 revenue consensus $1.32B.
16:09 EDTQGENQIAGEN reports Q2 adjusted EPS 26c, consensus 25c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use